Viewing StudyNCT00007839



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00007839
Status: UNKNOWN
Last Update Posted: 2013-12-18
First Post: 2001-01-06

Brief Title: Beta Alethine in Treating Patients With Low-Grade Lymphoma
Sponsor: LifeTime Pharmaceuticals
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2000-08
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2001-01-06
First Submit QC Date: October 7 2003
Study First Post Date: 2003-10-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-12-17
Last Update Post Date: 2013-12-18
Last Update Post Date Type: ESTIMATED